[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100544535":3},{"organization":4,"armGroups":7,"interventions":21,"overallOfficials":27,"centralContacts":31,"locations":40,"responsibleParty":124,"collaborators":10,"id":126,"slug":127,"hasResults":128,"nctId":129,"briefTitle":130,"officialTitle":131,"acronym":10,"eligibilityCriteria":132,"healthyVolunteers":133,"sex":134,"minAge":135,"maxAge":10,"enrollmentInfo":136,"targetDuration":10,"studyType":139,"phases":10,"briefSummary":140,"conditions":141,"keywords":147,"overallStatus":43,"whyStopped":10,"lastUpdateSubmitDate":153,"lastUpdatePostDateStruct":154,"startDateStruct":157,"completionDateStruct":159,"leadSponsor":161,"locationsCount":162},{"fullName":5,"class":6},"Memorial Sloan Kettering Cancer Center","OTHER",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"Participants with atrophic gastritis, intestinal metaplasia, and dysplasia",null,"Participants with presence of atrophic gastritis, intestinal metaplasia, and dysplasia and risk of the progression of these lesions",[13],"Behavioral: Questionnaire",{"label":15,"type":10,"description":16,"interventionNames":17},"Control Group","Healthy controls",[13],{"label":19,"type":10,"description":19,"interventionNames":20},"Participants with gastric cancer",[13],[22],{"type":23,"name":24,"description":25,"armGroupLabels":26,"otherNames":10},"BEHAVIORAL","Questionnaire","The questionnaire on clinical, environmental, lifestyle, and dietary risk factors will be administered",[15,9,19],[28],{"name":29,"affiliation":5,"role":30},"Monika Laszkowska, MD","PRINCIPAL_INVESTIGATOR",[32,36],{"name":29,"role":33,"phone":34,"phoneExt":10,"email":35},"CONTACT","212-639-6857","LaszkowM@mskcc.org",{"name":37,"role":33,"phone":38,"phoneExt":10,"email":39},"Xiang Shu, PhD","646-227-3658","ShuX@mskcc.org",[41,57,68,79,92,103,113],{"facility":42,"status":43,"city":44,"state":45,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)","RECRUITING","Basking Ridge","New Jersey","07920","United States","US",{"type":50,"coordinates":51},"Point",[52,53],-74.54932,40.70621,{"lat":53,"lon":52},[56],{"name":29,"role":33,"phone":34,"phoneExt":10,"email":10},{"facility":58,"status":43,"city":59,"state":45,"zip":60,"country":47,"countryCode":48,"cosmosGeoPoint":61,"geoPoint":65,"contacts":66},"Memorial Sloan Kettering Monmouth (All Protocol Activities)","Middletown","07748",{"type":50,"coordinates":62},[63,64],-74.11709,40.39428,{"lat":64,"lon":63},[67],{"name":29,"role":33,"phone":34,"phoneExt":10,"email":10},{"facility":69,"status":43,"city":70,"state":45,"zip":71,"country":47,"countryCode":48,"cosmosGeoPoint":72,"geoPoint":76,"contacts":77},"Memorial Sloan Kettering Bergen (Limited Protocol Activities)","Montvale","07645",{"type":50,"coordinates":73},[74,75],-74.02292,41.04676,{"lat":75,"lon":74},[78],{"name":29,"role":33,"phone":34,"phoneExt":10,"email":10},{"facility":80,"status":43,"city":81,"state":82,"zip":83,"country":47,"countryCode":48,"cosmosGeoPoint":84,"geoPoint":88,"contacts":89},"Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity)","Commack","New York","11725",{"type":50,"coordinates":85},[86,87],-73.29289,40.84288,{"lat":87,"lon":86},[90],{"name":91,"role":33,"phone":34,"phoneExt":10,"email":10},"Monika Laszkowska, PhD",{"facility":93,"status":43,"city":94,"state":82,"zip":95,"country":47,"countryCode":48,"cosmosGeoPoint":96,"geoPoint":100,"contacts":101},"Memorial Sloan Kettering Westchester (Limited Protocol Activities)","Harrison","10604",{"type":50,"coordinates":97},[98,99],-73.71263,40.96899,{"lat":99,"lon":98},[102],{"name":29,"role":33,"phone":34,"phoneExt":10,"email":10},{"facility":104,"status":43,"city":82,"state":82,"zip":105,"country":47,"countryCode":48,"cosmosGeoPoint":106,"geoPoint":110,"contacts":111},"Memorial Sloan Kettering Cancer Center (All protocol activites)","10065",{"type":50,"coordinates":107},[108,109],-74.00597,40.71427,{"lat":109,"lon":108},[112],{"name":29,"role":33,"phone":34,"phoneExt":10,"email":10},{"facility":114,"status":43,"city":115,"state":82,"zip":116,"country":47,"countryCode":48,"cosmosGeoPoint":117,"geoPoint":121,"contacts":122},"Memorial Sloan Kettering Nassau (Limited Protocol Activites)","Rockville Centre","11553",{"type":50,"coordinates":118},[119,120],-73.64124,40.65871,{"lat":120,"lon":119},[123],{"name":29,"role":33,"phone":34,"phoneExt":10,"email":10},{"type":125,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100544535","a-study-collecting-health-information-to-understand-and-prevent-gastric-cancer-100544535",false,"NCT06370143","A Study Collecting Health Information to Understand and Prevent Gastric Cancer","Gastric Cancer Prevention: Understanding Precursor Lesions and Risk Factors for Progression to Cancer","Inclusion Criteria:\n\n* Age ≥ 18 years old\n* Able to read and understand English and Spanish\n* Meet criteria for one of three potentially eligible study populations:\n\n  * Individuals with gastric atrophy, gastric intestinal metaplasia, or dysplasia: Had a previous diagnosis of or have been diagnosed by the investigation team with gastric atrophy, gastric intestinal metaplasia, or dysplasia of the gastric mucosa on pathology review from an endoscopic biopsy. Individuals who have a prior history of early gastric cancer may be included, if they were treated endoscopically and have no evidence of disease. Individuals who have a prior history of a cancer other than upper gastrointestinal cancer may also be included, if they have no evidence of disease for at least 1 year prior to study enrollment and are not undergoing active treatment for any malignancy at any time throughout the study period\n  * Healthy controls (average risk): Individuals with no history of cancer or gastric precursor lesions undergoing a clinically indicated endoscopy at MSK for workup or dyspepsia or reflux\n  * Gastric cancer cases: Individuals with a known diagnosis of early gastric adenocarcinoma undergoing surgical resection at MSK\n\nExclusion Criteria:\n\n* Age \\\u003C 18 years old\n* Women who are pregnant (may be enrolled after delivery)\n* Individuals with a prior history of upper gastrointestinal surgery or a prior cancer who are undergoing active treatment for malignancy or have been diagnosed within 1 year prior to the study enrollment or with pancreatic cancer. (This does not include incidentally diagnosed primary gastric adenocarcinoma identified during study follow up. Individuals diagnosed with gastric carcinoid limited to the stomach will also be included, given their ongoing parallel risk for gastric adenocarcinoma.)\n* Have severe comorbidities with expected survival time \\\u003C2 years or which would prevent them from undergoing routine elective EGD (at the discretion of the patient's provider and the study team)\n* Individuals having Hereditary Diffuse Gastric Cancer Syndrome, mutations including CDH1 and CTNNA1, or more than one genetic mutation\n* Exclude high risk esophageal and duodenal lesions including:\n\n  * Duodenal Adenoma\n  * Dysplasia or cancer at the esophagus or gastroesophageal junction\n* Patients with an increased risk for biopsies during EGD, such as those with clotting disorders.",true,"ALL","18 Years",{"count":137,"type":138},3200,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to create a registry of participants with precursor lesions for gastric cancer, including gastric atrophy, intestinal metaplasia, and dysplasia. Normal controls and individuals with gastric cancer for comparison of baseline characteristics will also be enrolled.",[142,143,144,145,146],"Gastric Atrophy","Gastric Intestinal Metaplasia","Dysplasia","Gastric Adenocarcinoma","Gastric Cancer",[148,149,150,143,151,5,152],"Gastric cancer","gastric adenocarcinoma","gastric atrophy","dysplasia","24-083","2026-01-28",{"date":155,"type":156},"2026-01-30","ACTUAL",{"date":158,"type":156},"2024-04-11",{"date":160,"type":138},"2036-04-11",{"name":5,"class":6},7]